Pfizer (PFE) net assets (shareholders' equity)

Net assets · fiscal 2025
$86.48B

Pfizer (PFE) had net assets of $86.48B at the end of fiscal 2025 (December 31, 2025). That is 2.0% lower than the $88.20B of fiscal 2024. Figures as of 18 Nov 2026, 20:13 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2025
$86.48B
Change on fiscal 2024
−2.0%
Growth, 5 years
+6.5% a year
Growth, 10 years
+2.9% a year
Highest on record
$95.66Bfiscal 2022
Lowest on record
$57.56Bfiscal 2008
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Pfizer net assets (shareholders' equity), in more detail

Over the five fiscal years to 2025 net assets grew at a compound 6.5% a year; over ten years the rate was 2.9% a year. Across the 19 fiscal years on record (2007–2025), the highest was $95.66B in fiscal 2022 and the lowest $57.56B in fiscal 2008.

History · 19 fiscal years

Net assets by fiscal year

Pfizer net assets (shareholders' equity), year by year

Pfizer (PFE) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$86.48B 2.0% down
2024$88.20B 0.9% down
2023$89.01B 6.9% down
2022$95.66B 23.9% up
2021$77.20B 22.1% up
2020$63.24B 0.2% up
2019$63.14B 0.4% down
2018$63.41B 11.1% down
2017$71.31B 19.8% up
2016$59.54B 8.0% down
2015$64.72B 9.2% down
2014$71.30B 6.6% down
2013$76.31B 6.1% down
2012$81.26B 1.1% down
2011$82.19B 6.4% down
2010$87.81B 2.4% down
2009$90.01B 56.4% up
2008$57.56B 11.6% down
2007$65.12B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Pfizer and comparable companies
CompanyNet assetsFiscal year
Novo Nordisk NVODKK 194.05B2025
Pfizer PFE$86.48B2025
Intuitive Surgical ISRG$17.82B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PFE

Pfizer, figure by figure

Pfizer (PFE) overview: price, valuation and scorecardAll health care companies by market value

Pfizer net assets (shareholders' equity): questions and answers

What are Pfizer's net assets?

Pfizer (PFE) had net assets of $86.48B at the end of fiscal 2025 (December 31, 2025). That is 2.0% lower than the $88.20B of fiscal 2024.

What is the growth rate of Pfizer's net assets?

Over the five fiscal years to 2025 net assets grew at a compound 6.5% a year; over ten years the rate was 2.9% a year.

What are the highest and lowest net assets figures on record for Pfizer?

Across the 19 fiscal years on record (2007–2025), the highest was $95.66B in fiscal 2022 and the lowest $57.56B in fiscal 2008.

How is Pfizer's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Pfizer it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pfizer (PFE) net assets (shareholders' equity)”, data as of 18 November 2026. https://funkfolio.com/stock/PFE/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.